A neutral triacylglycerol lipase activity that is separate and distinct from lipoprotein lipase (LPL) could be measured in homogenates of myocardial cells if protamine sulphate and high concentrations of albumin were included in the assay. This neutral lipase was predominantly particulate, with the highest relative specific activity in microsomal subcellular fractions. The induction of diabetes by the administration of streptozotocin to rats resulted in a decrease in LPL activity in myocyte homogenates and in particulate subcellular fractions, but the percentage of cellular LPL activity that was released during incubation of myocytes with heparin was normal. In contrast,-neutral lipase activity was increased in diabetic myocyte homogenates and microsomal fractions. Acid triacylglycerol lipase activity was not changed in diabetic myocytes. The decrease in LPL in myocytes owing to diabetes may result in the decreased functional LPL activity at the capillary endothelium of the diabetic heart.
INTRODUCTION
The functional fraction of LPL that results in the degradation of the TG component of circulating lipoproteins by the heart has been localized to the capillary endothelium, where it can be released by heparin Pedersen et al., 1983) . Diabetes results in a decrease in both very-lowdensity-lipoprotein and chylomicron degradation by perfused hearts (Kreisberg, 1966; O'Looney et al., 1983 O'Looney et al., , 1985 , but the effect of diabetes on heparin-releasable LPL is controversial. O'Looney et al. (1983) and Aktin & Meng (1972) have reported that heparin-releasable LPL was decreased in diabetic hearts, compared with control hearts. In contrast, Stam et al. (1984) found that heparin-releasable LPL was increased in the diabetic heart, and more LPL was reported to be released from slices of diabetic heart incubated with heparin than from control heart slices (Kessler, 1963) . The heparin-nonreleasable or residual LPL in cardiac tissue may be the precursor of the functional endothelium-bound enzyme (Ben-Zeev et al., 1981; Stam & Hiulsmann, 1983) . Diabetes has been reported either to decrease (O'Looney et al., 1983; Aktin & Meng, 1972) or to increase (Stam et al., 1984 ) the residual LPL after heparin perfusion of rat hearts.
When lipase assays are performed in the absence of the serum cofactor for LPL with fractions from heparinperfused hearts, TG lipase activity with both acid (pH 4.5-5) and neutral (pH 7-7.5) pH optima is observed (Severson, 1979; Rosen et al., 1981; Stam & Hiilsmann, 1983) . Stam & Hulsmann (1983) have proposed that the neutral lipase activity measured in the absence of serum is identical with LPL. Diabetes has been reported to decrease both acid and neutral TG lipase activities (Rosen et al., 1981; Stam et al., 1984) .
The interpretation of results with enzyme preparations from heparin-perfused hearts has the complication that lipase activities may reside in more than one cell type and/or in the interstitial spaces. Ramirez et al. (1985) have shown that isolated myocardial cells (myocytes) from rat heart contain a serum-independent neutral TG lipase (optimum pH 7) with several unique characteristics, in addition to an acid lysosomal lipase and LPL. This unique neutral lipase could be resolved from LPL by heparin-Sepharose chromatography, and immunotitration experiments with antibodies to LPL revealed that both the neutral lipase and LPL contributed to the overall TG lipase activity measured in the absence of serum with myocyte homogenates (Ramirez et al., 1985) . Therefore the first objective of the present investigation was to establish experimental conditions that would allow the determination of neutral lipase activity in myocyte homogenates without any contribution of LPL. The second objective was then to determine the effects of diabetes on the various lipase activities in myocytes from rat heart. The results indicate that LPL was decreased in diabetic myocytes, but that the neutral lipase activity was increased.
METHODS AND MATERUILS
Diabeteswasinduced by the intravenous administration of streptozotocin (100 mg/kg) to rats as described by Kenno & Severson (1985) . The diabetic rats were killed after 3-4 days. Ca2+-tolerant myocytes from control and diabetic rat hearts were isolated by the procedures outlined by Kenno & Severson (1985) .
Myocyte preparations were homogenized by sonication (Ramirez et al., 1985) . When indicated, acetone/etherdried powders of the cell homogenates were prepared by the procedures of Garfinkel & Schotz (1972) . In some experiments, subcellular fractions were obtained from myocyte homogenates by differential centrifugation (Chohan & Cryer, 1979; Wang et al., 1977 (Ramirez et al., 1985) . The following standard assay conditions were employed unless noted otherwise: for lipoprotein lipase, 0.6 mM-triolein (1.0 mCi/mmol), 25 mM-Pipes, pH 7.5, 0.05% (w/v) albumin, 50 mM-MgCl2, and 3 % (v/v) serum; for-neutral lipase, 0.6 mM-triolein (7.0 mCi/ mmol), 25 mM-Pipes, pH 7.0, 50 mM-MgCl2, 0.5% albumin, and 0.25 mg of protamine sulphate/ml; and for acid lipase, 0.6 mM-triolein (2.0 mCi/mmol), 25 mmacetate, .pH 5, 0.05 % albumin. The release of radiolabelled oleate was measured after 30 min incubations as described by Ramirez et al. (1985) .
Materials were as given by Ramirez et al. (1985) . Antibodies to rat heart LPL were generously given by Dr. M. C. Schotz, Wadsworth Medical Center, Los Angeles, CA, U.S.A.
RESULTS
Protamine sulphate or a high concentration of albumin inhibits LP-L (Stam & Hiilsmann, 1983; Eisenberg et al., 1981) , and so the effect of these compounds on LPL and neutral lipase activities, resolved by heparin-Sepharose chromatography after solubilization oflipase activities in myocyte homogenates by deoxycholate (Ramirez et al., 1985) , was examined (Table 1 ). The combination of protamine sulphate and albumin inhibited LPL activity to 3% of control when activity was measured in the absence of serum. Less inhibition was observed when assays contained serum, consistent with previous results with milk LPL, where apolipoprotein C-TI decreased the inhibition by albumin (Rapp & Olivecrona, 1978) . In contrast with these results with LPL, protamine ssulphate and albumin had no significant effect on neutral lipase activity in the unbound fraction (Table 1) . Since the inhibitory effects of protamine sulphate and albumin were selective for LPL, the effect of these agents on lipase activity in myocyte homogenates was examined next.
TG lipase activity in .myocyte homogenates measured at pH 7.0 in the presence of e rotamine sulphate and albumin was approx. 50% of-ift measured at pH 7.5 in the absence of serum (Table 2 ). This decrease is consistent with previous immunotitration results, where the addition of antibodies to LPL decreased TG lipase activity in myocyte homogenates measured in the absence of-serum to 55% of control (Ramirez et al., 1985) . (Table 3) . As observed previously (Ramirez et al., 1985) , anti-LPL IgG produced a greater inhibition (63% ) of serum-stimulated activity than that measured in the absence of serum (43%). These results are consistent with the conclusion (Ramirez et al., 1985) that both LPL and a neutral lipase contribute to lipase activity measured in the absence of serum. The same results were obtained when 300 ,ug of antibody to LPL was utilized. However, the anti-LPL IgG fraction had no effect on lipase activity measured at pH 7 in the presence of protamine sulphate and albumin (Table 3) . Therefore, even though serum does produce a stimulation of TG lipase activity measured in the presence of protamine sulphate and albumin, LPL must not contribute significantly to lipase activity measured in the absence of serum.
Similar results to those in Table 3 were also obtained when lipase activity in myocyte homogenates was measured in the presence of high ionic strength. The resolved neutral lipase after heparin-Sepharose chromatography was activated by 1.0 M-NaCl, whereas the purified LPL was markedly inhibited (Ramirez et al., 1985) . The presence of 1.0 M-NaCl decreased lipase activity in myocyte homogenates measured at pH 7.0 to 38 + 2% (n = 4) of the activity measured at pH 7.5 in the presence of 50 mM-MgC12. The antibody to LPL resulted in only a slight decrease in lipase activity (from 14.3 to 12.1 nmol/h per 106 cells) measured in the presence of 1.0 M-NaCl. Therefore, two different conditions that inhibit LPL activity allowed the determination of neutral lipase activity in myocyte homogenates. Furthermore, the experiments with high ionic strength lessen the possibility that the lack of effect of the antibody on lipase activity measured in the presence of protamine sulphate and albumin (Table 3 ) was due to these reagents somehow interfering with the action of the antibody. Lipase activity in myocyte homogenates was consistently greater when assayed in the presence of 50 mM-MgCl2, protamine sulphate and albumin as compared with assays with 1.0 M-NaCl, owing to the greater stimulation of neutral lipase activity by 50 mM-MgCl2 than by 1.0 M-NaCl (Ramirez et al., 1985) , and so these experimental conditions were utilized in further investigations.
Assays for neutral lipase at pH 7.0 and with 50 mM-MgCl2, 0.25 mg of protamine sulphate/ml and 5 mg of albumin/ml were linear for up to 60 min of incubation with up to 300 ,ug of protein per incubation. LPL in rat heart myocytes has been found to be predominantly particulate, with the highest relative specific activity (% total activity/% total protein) in microsomal fractions (Chohan & Cryer, 1979; Ramirez et al., 1985) . For the neutral lipase, 90% of the total recovered activity in subcellular fractions was also particulate, and the highest relative specific activity (4.4 + 0.8; n = 6) was in the microsomal fraction. When myocytes were treated with deoxycholate to solubilize the lipase activities, 92% of the total recovered TG lipase activity determined in the presence of MgCl2, protamine sulphate and albumin was recovered in the unbound fraction after heparin-Sepharose chromatography (mean oftwo experiments), providing additional evidence that LPL does not contribute significantly to the lipase activity measured under these experimental conditions. LPL activity has been determined in acetone/etherdried powder preparations from myocytes (Chohan & Cryer, 1979 Vahouny et al., 1980; Palmer & Kane, 1983) , and so the activity of the neutral lipase and acid lipase was also determined in acetone/ether-dried powders (Table 2) . LPL activity was increased in the powders; similar results have been reported in other Vol. 238 (Chohan & Cryer, 1979 Vahouny et al., 1980) and with acetone/ether-dried powder preparations from whole heart (Borenzstajn et al., 1970) . In contrast, the neutral and acid lipase activities were decreased substantially in acetone/etherdried powders (Table 2) ; the decrease in acid lipase activity in the powders is likely to be due to the removal of essential phospholipid(s), as observed with rat liver lysosomal TG lipase (Teng & Kaplan, 1974) . Therefore, the influence of diabetes on lipase activities was determined in experiments with sonicated homogenates of myocytes only.
The induction of diabetes in rats was characterized by a significant weight loss and a plasma glucose concentration of 23.3 + 0.6 mM (n = 8); control rats had a plasma glucose concentration of 9.1 + 0.4 mM (n = 8).
The diabetic condition did not influence the yield or viability of isolated myocytes. The yield of myocytes from a single control or diabetic rat heart was l1.1(+0.9)x 106 (n = 7) or 8.7(±1.0)x 106 cells (n = 8) respectively. The viability, assessed as the percentage of rod-shaped cells that excluded Trypan Blue, was 79 + 2% and 75 + 3% for control and diabetic myocytes respectively. As shown in Table 4 , LPL activity was decreased in homogenates from diabetic myocytes, but the neutral lipase activity was increased significantly. Diabetes did not influence the characteristics of LPL in vitro. Optimal serum stimulation was still obtained at an ionic strength of either 0.15 M (MgCl2) or 0.2 M (NaCl), as we previously reported for LPL in control myocyte homogenates (Ramirez et al., 1985) . Lipase activity in diabetic-myocyte homogenates was stimulated by apolipoprotein C-II, and C-IT-stimulated activity was decreased by the addition of apolipoprotein C-I4l2 (results not shown). Diabetes had no effect on acid lipase activity (Table 4) .
The total yield of protein in control and diabetic myocytes was 6.1 +0.-6 (n = 5) and 5.7 + 0.4 (n = 7) mg/106 cells respectively, and the percentage distribution of protein in the various subcellular fractions was not changed in diabetic myocytes. The effect of diabetes on the specific activities of the neutral lipase and LPL in subcellular fractions from control and diabetic-myocyte homogenates is shown in Table 5 . For the neutral lipase, the increase in specific activity owing to diabetes was restricted to the microsomal fraction, whereas a lower specific activity for LPL was evident in all the particulate fractions from diabetic myocytes (Table 5) . Chohan & Cryer (1980) have demonstrated that the incubation of myocytes with heparin resulted in the release of LPL into the medium, together with an increase in total activity (cells plus medium). Therefore the effect of heparin on the release of LPL was studied with control and diabetic myocytes (Table 6) . After a 20 min incubation with heparin, the activity of LPL in the medium and in the cells was significantly lower for incubations of diabetic myocytes. However, the percentage of the total LPL that was released into the medium 1986 from diabetic myocytes (17.8 + 3 % ) was not significantly different from that (22.7 + 1.9% ) from control myocytes (Table 6 ).
DISCUSSION
The effect of diabetes on LPL activity in cardiac tissue has been the subject of a number of investigations, but the interpretation of some observed changes in activity has been complicated in some cases because whole heart preparations were used, where LPL activity was not separated into heparin-releasable and non-releasable fractions (Kessler, 1963; Rauramaa et al., 1980; Nakai et al., 1984; Nomura et al., 1984) . Even when investigations were performed with the heparin-nonreleasable or residual LPL (Aktin & Meng, 1972; O'Looney et al., 1983; Stam et al., 1984) , enzyme activity will exist in several compartments, since LPL activity has been measured in the cardiac interstitium (Hulsmann et al., 1982) and in both cultured mesenchymal cells (Chajek et al., 1977 (Chajek et al., , 1978 and myocytes (Bagby et al., 1977; Chohan & Cryer, 1979 Vahouny et al., 1980; Ramirez et al., 1985) . In the present investigation, LPL activity (characterized by stimulation by serum and apolipoprotein C-Il and inhibition by apolipoprotein C-Il12) was decreased in sonicated homogenates and particulate subcellular fractions from diabetic myocytes (Tables 4 and 5 ). This decrease in myocyte LPL activity owing to diabetes is consistent with the observations by O'Looney et al. (1983) and Aktin & Meng (1972) that the heparin-non-releasable (residual) LPL was decreased in diabetic hearts.
There is no apparent explanation for the discrepancy between these results and the observations that diabetes can result in increased LPL activity in heparin-perfused hearts (Stam et al., 1984) and in acetone/ether-dried powders from whole hearts (Kessler, 1963) .
The LPL in myocytes is probably the precursor for the functional enzyme at the capillary endothelium. In this regard, it is of interest that the amount of LPL released into the medium after incubation with heparin was lower in diabetic than in control cells (Table 6 ). However, the percentage of total activity released by heparin was not affected, suggesting that the secretory mechanism is not influenced by diabetes, and thus the lower LPL activity secreted from diabetic cells would be merely the consequence of the lower activity inside the cells. Therefore the lower activity of LPL in the diabetic myocytes could account for the decrease in functional LPL activity, which results, in part, in the decreased catabolism in lipoproteins by the diabetic heart (Kreisberg, 1966; O'Looney et al., 1983 O'Looney et al., , 1985 . In contrast, starvation increased LPL activity bound at the capillary endothelium , but LPL activity in myocyte preparations was not changed (Chohan & Cryer, 1979) .
A previous investigation from this laboratory identified a neutral TG lipase in rat heart myocytes that was separate and distinct from LPL (Ramirez et al., .1985) . This neutral lipase was present in the unbound fraction from heparin-Sepharose columns, had a pH optimum of 7, and was stimulated by 50 mM-MgCl2 and 1 M-NaCl. In addition, the neutral lipase was not stimulated by serum, and was not inhibited by antibodies to LPL. When myocyte homogenates are assayed at pH 7.5 in the absence of serum, both LPL and the neutral lipase contribute to the measured TG lipase activity, since antibodies to LPL decrease the lipase activity by about 45% (Ramirez et al., 1985;  Table 3 ). However, the selective inhibition of LPL with protamine sulphate and albumin (Table 1 ) allowed the determination of the neutral lipase in myocyte homogenates. The inhibition of LPL in myocyte homogenates by protamine sulphate and albumin was not complete, since serum still increased lipase activity. However, the contribution of LPL to lipase activity measured in the absence of serum and in the presence of protamine sulphate and albumin was not significant, since an antibody to LPL did not decrease lipase activity under these conditions (Table 3) . Furthermore, lipase activity measured with protamine sulphate and albumin was almost exclusively recovered in the unbound fraction after heparin-Sepharose chromatography; any LPL activity expressed under these conditions would have been eluted at 1.2 M-NaCl. It was possible, then, to show that diabetes increased neutral lipase activity (Table 4) . Furthermore, the neutral lipase was mainly particulate, and the diabetes-induced increase in specific activity was restricted to the microsomal fraction (Table 5 ). Previous results showing that diabetes decreased neutral lipase activity measured in the absence of serum with fractions from heparin-perfused hearts (R6sen et al., 1981; Stam et al., 1984) can be explained by the greater contribution of LPL to the lipase assays under those conditions.
A lysosomal TG lipase is also present in myocytes from rat heart (Ramirez et al., 1985) , but diabetes had no effect on acid lipase activity (Table 4 ). This result is in contrast with other studies, which reported that acid lipase was decreased in diabetic heart preparations (Rosen et al., 1981; Stam et al., 1984) . One possible explanation for this discrepancy is that the changes produced by diabetes in whole heart preparations could have occurred in cell types other than myocytes. Lysosomes are present in cardiac macrophages as well as in myocytes, and these distinct lysosomal populations differ with respect to their content of acid hydrolases (Franson et al., 1972; Welman & Peters, 1976) .
The determination of the effect of diabetes on intracellular lipase activities in myocytes is also of interest with respect to the regulation of the mobilization of endogenous stores of TG (lipolysis) in myocytes. Diabetes results in an elevation in the content of TG in hearts (R6sen et al., 1981) and myocytes (Kenno & Severson, 1985) , and perfusion of diabetic hearts or incubation of isolated myocytes results in enhanced rates of lipolysis as monitored by glycerol output (Kreisberg, 1966; Rosen et al., 1981; Kenno & Severson, 1985) . Further investigations will have to determine which of the intracellular lipase activities is responsible for determining the rate of lipolysis in myocytes, and how this lipase is regulated.
